- Moderna struck a deal with Chinese officials to research, develop and manufacture messenger RNA medicines in the country, despite rising tensions between the U.S. and China.
- The Massachusetts-based biotech company will develop those drugs “exclusively for the Chinese people,” a spokesperson told CNBC.
- Moderna is trying to capitalize on the success of its Covid vaccine, which uses a platform called mRNA to teach human cells to produce an immune response against a virus.
